<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04721405</url>
  </required_header>
  <id_info>
    <org_study_id>NWCT20-SS-003</org_study_id>
    <nct_id>NCT04721405</nct_id>
  </id_info>
  <brief_title>Evaluation of Non-Invasive Assessment for Post RFAL Procedure Monitoring Using the Nanowear Wearable Multiple Sensor Vest</brief_title>
  <official_title>Evaluation of Non-Invasive Assessment for Post RFAL Procedure Monitoring Using the Nanowear Wearable Multiple Sensor Vest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanowear Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanowear Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate an experience of post-operative monitoring using&#xD;
      the Nanowear wearable multiple sensor vest in plastic surgery&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Subject assessment of comfort and compliance</measure>
    <time_frame>7 days</time_frame>
    <description>1. Subject assessment of comfort and compliance will be filled out by subjects using a 6-points Usability Survey, as follows:&#xD;
Overall Size of the device - 0 - Being the largest device 5 -Being the smallest.&#xD;
Secrecy - If patient's are uneasy of people knowing they are wearing a medical device. 0 - Not able to hide 5 - Discrete&#xD;
Adaptable to size - Can devices be used on all size patients, extreme scales. 0- Not adjustable 5- Can fit all sizes&#xD;
Device Material - Is the material comfortable to wear. 0 - Uncomfortable 5 - Comfortable&#xD;
Active Wear - Can patient's wear the device while exercising. 0- Not at all 5 - Can exercise without interference.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Investigator assessment of device usability and satisfaction</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>2. Investigator assessment of device usability will be filled out by PI using a 4-points Likert scale, as follows: 3 = Extremely useful in post op care; 2 = Useful in post op care; 1 = Somewhat useful in post op care; 0 = Useless in post op care.&#xD;
3. Investigator assessment of satisfaction will be filled out by PI using a 5-points Likert scale, as follows:&#xD;
+2 = Very satisfied; +1 = Satisfied; 0 = Indifferent; -1 = Disappointed; -2 = Extremely disappointed.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Elective Surgical Procedures</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Observational Study: No intervention</intervention_name>
    <description>Observational Study: No intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female over the age of 18 years, healthy adults scheduled to undergo BodyTite&#xD;
        and/or FaceTite procedures.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signed informed consent to participate in the study.&#xD;
&#xD;
          -  Female and male subjects, at least 18 years of age at the time of enrolment&#xD;
&#xD;
          -  The patient is scheduled to undergo BodyTite and/or FaceTite procedures.&#xD;
&#xD;
          -  The patients should be willing to comply with the study procedure and schedule.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pacemaker or internal defibrillator, or any other active electrical implant anywhere&#xD;
             in the body.&#xD;
&#xD;
          -  Pregnancy and nursing.&#xD;
&#xD;
          -  Subject unwilling or unable to comply with wearing the Nanowear System 12 hours daily&#xD;
             for at least 48 hours Up to 7 days&#xD;
&#xD;
          -  As per the practitioner's discretion, refrain from treating any condition that might&#xD;
             make it unsafe for the patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria Shusterman</last_name>
    <phone>4164589001</phone>
    <email>maria.shusterman@inmodemd.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zucker School of Medicine, Hofstra University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Shusterman</last_name>
      <phone>416-458-9001</phone>
      <email>maria.shusterman@inmodemd.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Delvecchio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>January 21, 2021</last_update_submitted>
  <last_update_submitted_qc>January 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

